Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000206444 | SCV000261503 | benign | Multiple endocrine neoplasia, type 2 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Vantari Genetics | RCV000210769 | SCV000267087 | benign | Hereditary cancer-predisposing syndrome | 2016-02-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000242363 | SCV000313731 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Counsyl | RCV000411696 | SCV000489797 | benign | Multiple endocrine neoplasia type 2B | 2016-03-28 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000409257 | SCV000489798 | benign | Multiple endocrine neoplasia type 2A | 2016-03-28 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001675672 | SCV000605027 | benign | not provided | 2024-03-20 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000242363 | SCV000704091 | benign | not specified | 2016-12-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000242363 | SCV001476552 | benign | not specified | 2019-10-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001675672 | SCV001892595 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 21542403) |
Sema4, |
RCV000210769 | SCV002527930 | benign | Hereditary cancer-predisposing syndrome | 2020-09-01 | criteria provided, single submitter | curation | |
KCCC/NGS Laboratory, |
RCV000411696 | SCV004017349 | benign | Multiple endocrine neoplasia type 2B | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000409257 | SCV004018070 | benign | Multiple endocrine neoplasia type 2A | 2023-04-18 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |
Breakthrough Genomics, |
RCV001675672 | SCV005319273 | benign | not provided | criteria provided, single submitter | not provided | ||
KCCC/NGS Laboratory, |
RCV005235112 | SCV005881239 | benign | Pheochromocytoma | 2025-02-01 | criteria provided, single submitter | clinical testing |